Cheminformatic comparison of approved drugs from natural product versus synthetic origins Journal Article


Authors: Stratton, C. F.; Newman, D. J.; Tan, D. S.
Article Title: Cheminformatic comparison of approved drugs from natural product versus synthetic origins
Abstract: Despite the recent decline of natural product discovery programs in the pharmaceutical industry, approximately half of all new drug approvals still trace their structural origins to a natural product. Herein, we use principal component analysis to compare the structural and physicochemical features of drugs from natural product-based versus completely synthetic origins that were approved between 1981 and 2010. Drugs based on natural product structures display greater chemical diversity and occupy larger regions of chemical space than drugs from completely synthetic origins. Notably, synthetic drugs based on natural product pharmacophores also exhibit lower hydrophobicity and greater stereochemical content than drugs from completely synthetic origins. These results illustrate that structural features found in natural products can be successfully incorporated into synthetic drugs, thereby increasing the chemical diversity available for small-molecule drug discovery. © 2015 Elsevier Ltd. All rights reserved.
Keywords: drug approval; drug structure; pharmacophore; natural product; physical chemistry; natural products; drug; principal component analysis; hydrophobicity; cheminformatics; physicochemical properties; article; synthetic drugs
Journal Title: Bioorganic & Medicinal Chemistry Letters
Volume: 25
Issue: 21
ISSN: 0960-894X
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2015-11-01
Start Page: 4802
End Page: 4807
Language: English
DOI: 10.1016/j.bmcl.2015.07.014
PROVIDER: scopus
PMCID: PMC4607632
PUBMED: 26254944
DOI/URL:
Notes: Export Date: 2 November 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Derek S Tan
    92 Tan